Gene · 84876
Papers3,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress-Role of New Drugs, Flozins. | Biomedicines | 2023 | 37626732 | PubTator, text mining | PubMed |
| The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. | Cell Death Dis | 2023 | 37620336 | PubTator, text mining | PubMed |
| Diversity and complexity of cell death: a historical review. | Exp Mol Med | 2023 | 37612413 | PubTator, text mining | PubMed |
| PtdSer as a signaling lipid determined by privileged localization of ORP5 and ORP8 at ER/PM junctional foci to determine PM and ER PtdSer/PI(4)P ratio and cell function. | Proc Natl Acad Sci U S A | 2023 | 37607230 | PubTator, text mining | PubMed |
| Store-operated calcium entry mediates hyperalgesic responses during neuropathy. | FEBS Open Bio | 2023 | 37606998 | PubTator, text mining | PubMed |
| MicroRNAs miR-16 and miR-519 control meningioma cell proliferation via overlapping transcriptomic programs shared with the RNA-binding protein HuR. | Front Oncol | 2023 | 37601663 | PubTator, text mining | PubMed |
| ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer. | Transl Cancer Res | 2023 | 37588742 | PubTator, text mining | PubMed |
| Characterization of the TRPV6 calcium channel-specific phenotype by RNA-seq in castration-resistant human prostate cancer cells. | Front Genet | 2023 | 37576552 | PubTator, text mining | PubMed |
| Intracellular Ca2+ signalling: unexpected new roles for the usual suspect. | Front Physiol | 2023 | 37576340 | PubTator, text mining | PubMed |
| New Insights into the Reparative Angiogenesis after Myocardial Infarction. | Int J Mol Sci | 2023 | 37569674 | PubTator, text mining | PubMed |
| New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma. | Cancers (Basel) | 2023 | 37568808 | PubTator, text mining | PubMed |
| Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review. | Allergy Asthma Clin Immunol | 2023 | 37559153 | PubTator, text mining | PubMed |
| Deletion of TRPC6, an Autism Risk Gene, Induces Hyperexcitability in Cortical Neurons Derived from Human Pluripotent Stem Cells. | Mol Neurobiol | 2023 | 37552395 | PubTator, text mining | PubMed |
| TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination. | J Exp Clin Cancer Res | 2023 | 37542345 | PubTator, text mining | PubMed |
| Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling. | Exp Mol Med | 2023 | 37524877 | PubTator, text mining | PubMed |
| An oncogenic isoform of septin 9 promotes the formation of juxtanuclear invadopodia by reducing nuclear deformability. | Cell Rep | 2023 | 37516960 | PubTator, text mining | PubMed |
| Purinergic Activation of Store-Operated Calcium Entry (SOCE) Regulates Cell Migration in Metastatic Ovarian Cancer Cells. | Pharmaceuticals (Basel) | 2023 | 37513856 | PubTator, text mining | PubMed |
| Delineating Zinc Influx Mechanisms during Platelet Activation. | Int J Mol Sci | 2023 | 37511448 | PubTator, text mining | PubMed |
| A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma. | Int J Mol Sci | 2023 | 37511120 | PubTator, text mining | PubMed |
| Secretion of Interleukin 6 in Human Skeletal Muscle Cultures Depends on Ca2+ Signalling. | Biology (Basel) | 2023 | 37508398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84876/papers?page=18